Malachite Innovations, Inc. (MLCT)
| Market Cap | 8.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.93M |
| Shares Out | 51.45M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 700 |
| Open | 0.160 |
| Previous Close | 0.170 |
| Day's Range | 0.160 - 0.170 |
| 52-Week Range | 0.120 - 0.500 |
| Beta | 3.08 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About MLCT
Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situatio... [Read more...]
News
MALACHITE INNOVATIONS ANNOUNCES CLOSING OF $3.0 MILLION CAPITAL RAISE AND INITIAL ESG ACQUISITIONS
CLEVELAND, OHIO, May 13, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”) announces the closing of a $3.0 million capital raise and purchase of 80% of the common stock...
MALACHITE INNOVATIONS ANNOUNCES SIGNED LETTER OF INTENT WITH RANGE ENVIRONMENTAL RESOURCES, INC.
CLEVELAND, OHIO, March 15, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”) announces that it has entered into a non-binding letter of intent (the “Letter of Intent”) ...
MALACHITE INNOVATIONS ANNOUNCES TWO GRANTED U.S. PATENTS AND NEW PCT PATENT FILING
CLEVELAND, OHIO, Dec. 28, 2021 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) announces that its wholly-owned drug development subsidiary, Graphium Biosciences, Inc., has been granted ...
Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
CLEVELAND, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC Mkts: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeuti...